4D Molecular Therapeutics Inc (25)
Browse by Contract Category
Contracts
-
Offer Letter, dated January 4, 2019 between August Moretti and the Registrant
(Filed With SEC on December 7, 2020)
-
Amended and Restated Investors Rights Agreement, dated as of April 29, 2020, among the Registrant and the investors party thereto
(Filed With SEC on December 7, 2020)
-
Employment Agreement, dated January 15, 2019 between Peter Francis, M.D., Ph.D. and the Registrant
(Filed With SEC on December 7, 2020)
-
Exclusive License and Bailment Agreement, dated December 19, 2013, between the Registrant and The Regents of the University of California
(Filed With SEC on December 7, 2020)
-
Form of Indemnification Agreement for directors and officers
(Filed With SEC on December 7, 2020)
-
Offer Letter, dated March 20, 2015 between David Kirn, M.D. and the Registrant
(Filed With SEC on December 7, 2020)
-
Exclusive License and Bailment Agreement, dated December 19, 2013, between the Registrant and The Regents of the University of California
(Filed With SEC on December 7, 2020)
-
2020 Employee Stock Purchase Plan
(Filed With SEC on December 7, 2020)
-
Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2020 Incentive Award Plan
(Filed With SEC on December 7, 2020)
-
Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under the 2020 Incentive Award Plan
(Filed With SEC on December 7, 2020)
-
Form of Stock Option Grant Notice and Stock Option Agreement under the 2020 Incentive Award Plan
(Filed With SEC on December 7, 2020)
-
2020 Incentive Award Plan
(Filed With SEC on December 7, 2020)
-
Form of Common Stock Certificate
(Filed With SEC on December 7, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on December 7, 2020)
-
Exclusive License and Bailment Agreement, dated December 19, 2013, between the Registrant and The Regents of the University of California
(Filed With SEC on November 17, 2020)
-
Exclusive License and Bailment Agreement, dated December 19, 2013, between the Registrant and The Regents of the University of California
(Filed With SEC on November 17, 2020)
-
Collaboration and License Agreement, dated August 6, 2019, by and between the Registrant and uniQure biopharma B.V
(Filed With SEC on November 17, 2020)
-
Amended and Restated Collaboration and License Agreement, dated August 6, 2019, between the Registrant and uniQure biopharma B.V
(Filed With SEC on November 17, 2020)
-
Collaboration and License Agreement, dated November 16, 2017, among the Registrant, F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc
(Filed With SEC on November 17, 2020)
-
Form of Stock Option Agreement under 2015 Equity Incentive Plan
(Filed With SEC on November 17, 2020)
-
2015 Equity Incentive Plan
(Filed With SEC on November 17, 2020)
-
Amended and Restated Investors Rights Agreement, dated as of April 29, 2020, among the Registrant and the investors party thereto
(Filed With SEC on November 17, 2020)
-
2015 Equity Incentive Plan
(Filed With SEC on September 30, 2019)
-
Form of Stock Option Agreement under 2015 Equity Incentive Plan
(Filed With SEC on September 30, 2019)
-
Amended and Restated Investors Rights Agreement, dated as of August 27, 2018, among the Registrant and the investors party thereto
(Filed With SEC on September 30, 2019)